NO20055485D0 - Vannloselige salter av risperidon - Google Patents

Vannloselige salter av risperidon

Info

Publication number: NO20055485D0
Authority: NO; Norway
Prior art keywords: risperidone; water; soluble salts; salts; soluble
Prior art date: 2003-04-22

Application number

NO20055485A

Other languages

English (en)

Other versions

NO20055485L (no

Inventor

Reinerus Gerardus Gieling

Desiree Laurant

Original Assignee

Synthon Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-22

Filing date

2005-11-21

Publication date

2005-11-21

2005-11-21 Application filed by Synthon Bv filed Critical Synthon Bv

2005-11-21 Publication of NO20055485D0 publication Critical patent/NO20055485D0/no

2006-01-23 Publication of NO20055485L publication Critical patent/NO20055485L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20055485A 2003-04-22 2005-11-21 Vannloselige salter av risperidon NO20055485L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US46436403P	2003-04-22	2003-04-22
PCT/EP2004/004128 WO2004094414A1 (en)	2003-04-22	2004-04-15	Water soluble salts of risperidone

Publications (2)

Publication Number	Publication Date
NO20055485D0 true NO20055485D0 (no)	2005-11-21
NO20055485L NO20055485L (no)	2006-01-23

Family

ID=33310877

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO20055485A NO20055485L (no)	2003-04-22	2005-11-21	Vannloselige salter av risperidon
NO20055490A NO20055490L (no)	2003-04-22	2005-11-21	Risperidon monohydroklorid

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
NO20055490A NO20055490L (no)	2003-04-22	2005-11-21	Risperidon monohydroklorid

Country Status (5)

Country	Link
US (2)	US20040266791A1 (no)
EP (2)	EP1615923A1 (no)
AR (2)	AR044055A1 (no)
NO (2)	NO20055485L (no)
WO (2)	WO2004094415A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050232995A1 (en)	2002-07-29	2005-10-20	Yam Nyomi V	Methods and dosage forms for controlled delivery of paliperidone and risperidone
EP1708790B1 (en) *	2003-12-02	2010-04-21	PharmaNeuroBoost N.V.	Use of pipamperone and a d2-receptor antagonist or a serotonin/dopamin antagonist for the treatment of psychotic disorders
US7884096B2 (en) *	2003-12-02	2011-02-08	Pharmaneuroboost N.V.	Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
EP1695973A1 (en) *	2005-02-24	2006-08-30	Neuro3D	Ocaperidone salt and pharmaceutical compositions containing the same
US8852638B2 (en)	2005-09-30	2014-10-07	Durect Corporation	Sustained release small molecule drug formulation
WO2008153611A2 (en)	2007-05-25	2008-12-18	Qlt Usa, Inc.	Sustained delivery formulations of risperidone compounds
US9561352B2 (en) *	2009-03-12	2017-02-07	Delpor, Inc.	Implantable device for long-term delivery of drugs
ES2607497T3 (es) *	2011-04-25	2017-03-31	Shandong Luye Pharmaceutical Co., Ltd.	Composición de risperidona de microesferas de liberación controlada
HUE028159T2 (en)	2011-04-26	2016-12-28	Torrent Pharmaceuticals Ltd	Acid addition salts of risperidone and pharmaceutical compositions containing them
AU2014249008B2 (en)	2013-03-11	2018-12-06	Durect Corporation	Injectable controlled release composition comprising high viscosity liquid carrier
WO2016149561A1 (en) *	2015-03-17	2016-09-22	Oak Crest Institute Of Science	Subdermal implants for the sustained delivery of water-soluble drugs
TW202313047A (zh)	2021-09-21	2023-04-01	西班牙商禾霏藥品實驗室有限公司	抗精神病可注射儲積型組合物
AU2023281232A1 (en)	2022-05-18	2024-10-24	Laboratorios Farmacéuticos Rovi, S.A.	Prolonged-release injectable compositions for use in treatment with risperidone together with cyp2d6 enzyme inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4335127A (en) *	1979-01-08	1982-06-15	Janssen Pharmaceutica, N.V.	Piperidinylalkyl quinazoline compounds, composition and method of use
US4342870A (en) *	1980-03-28	1982-08-03	Janssen Pharmaceutica N.V.	Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US4443451A (en) *	1981-07-15	1984-04-17	Janssen Pharmaceutica N.V.	Bicyclic pyrimidin-5-one derivatives
US4485107A (en) *	1982-11-01	1984-11-27	Janssen Pharmaceutica N.V.	[[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4804663A (en) *	1985-03-27	1989-02-14	Janssen Pharmaceutica N.V.	3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US5158952A (en) *	1988-11-07	1992-10-27	Janssen Pharmaceutica N.V.	3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use
GB9008850D0 (en) *	1990-04-19	1990-06-13	Janssen Pharmaceutica Nv	Novel 2,9-disubstituted-4h-pyridol(1,2-a)pyrimidin-4-ones
TW376319B (en) *	1993-04-28	1999-12-11	Janssen Pharmaceutica Nv	Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
US5453425A (en) *	1994-07-11	1995-09-26	Janssen Pharmaceutica N.V.	Risperidone oral formulation

2004
- 2004-04-15 EP EP04727562A patent/EP1615923A1/en not_active Withdrawn
- 2004-04-15 WO PCT/EP2004/004129 patent/WO2004094415A1/en not_active Ceased
- 2004-04-15 EP EP04727566A patent/EP1615924A1/en not_active Withdrawn
- 2004-04-15 WO PCT/EP2004/004128 patent/WO2004094414A1/en not_active Ceased
- 2004-04-16 US US10/825,684 patent/US20040266791A1/en not_active Abandoned
- 2004-04-16 US US10/825,683 patent/US20040266790A1/en not_active Abandoned
- 2004-04-22 AR ARP040101359A patent/AR044055A1/es not_active Application Discontinuation
- 2004-04-22 AR ARP040101358A patent/AR044054A1/es not_active Application Discontinuation
2005
- 2005-11-21 NO NO20055485A patent/NO20055485L/no not_active Application Discontinuation
- 2005-11-21 NO NO20055490A patent/NO20055490L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
WO2004094415A1 (en)	2004-11-04
WO2004094414A1 (en)	2004-11-04
EP1615923A1 (en)	2006-01-18
NO20055485L (no)	2006-01-23
NO20055490D0 (no)	2005-11-21
US20040266791A1 (en)	2004-12-30
AR044055A1 (es)	2005-08-24
EP1615924A1 (en)	2006-01-18
AR044054A1 (es)	2005-08-24
US20040266790A1 (en)	2004-12-30
NO20055490L (no)	2006-01-23

Publication	Publication Date	Title
NO20043660L (no)	2004-10-12	Salter av valsartan
ATE481402T1 (de)	2010-10-15	Pyrazolopyridin-derivate
NO2017051I2 (no)	2018-11-19	Kariprazin, eventuelt i form av et salt
CY2016046I1 (el)	2017-11-14	Κιναζολινονες ως αναστολεις της ανθρωπινης 3-κινασης δελτα της φωσφατιδυλινοσιτολης
DE60336732D1 (de)	2011-05-26	Azaindol-kinaseinhibitoren
DK1663232T3 (da)	2008-02-04	Benzimidazolderivater som human chymase-inhibitorer
CY2014018I1 (el)	2015-12-09	Kαρβαμιδο - υποκατεστημενες πυραζολοπυριδινες
NO20033815L (no)	2003-09-09	Farmasöytiske salter
DK1594840T3 (da)	2007-02-05	Piperidin-benzensulfonamid-derivater
DK1944305T3 (da)	2012-01-30	Quinolinderivater som phosphodiesteraseinhibitorer
ATE501135T1 (de)	2011-03-15	Piperidinamino-benzimidazol-derivate al respiratorisches syncytialvirus replikation inhibitoren
ATE384696T1 (de)	2008-02-15	Mandelsäure derivate
CY2017048I1 (el)	2018-09-05	Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
ATE415400T1 (de)	2008-12-15	Pyrazolopyridinderivate
DE602004004553D1 (de)	2007-03-15	Chinazolinderivate
DE602004022180D1 (de)	2009-09-03	Chinazolinderivate
IS8318A (is)	2006-02-21	N3-staðgengnir imidasópýridín c-kit tálmar
ATE395345T1 (de)	2008-05-15	Imidazol-4-yl-ethynyl-pyridin-derivate
NO20052474D0 (no)	2005-05-23	Amort form av esomeprazolsalter
JP2006502186A5 (ja)	2007-06-07	β-グルカンの使用
NO20055485D0 (no)	2005-11-21	Vannloselige salter av risperidon
DK1753764T3 (da)	2009-02-16	Pyrrolopyridin-derivater
NO20054763D0 (no)	2005-10-17	Salts of clopidogrel and process for preparation
DK1682129T3 (da)	2007-06-11	N-thiazol-2-ylbenzamidderivater
IS8242A (is)	2006-01-19	Nikótínamíð afleiður nytsamlegar sem PDE4 hindrar

Legal Events

Date	Code	Title	Description
2007-11-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application